Skip to main content
Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt flag Egypt · Delayed Price · Currency is EGP
5.64
+0.14 (2.55%)
At close: Nov 12, 2026

EGX:SIPC Financials Overview

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
40.7254.8822.7813.3118.245.42
Revenue Growth
-6.30%140.93%71.17%-26.88%-59.93%-34.89%
Gross Profit
12.4222.032.849.87.3118.75
Operating Income
-3.3112.34-8.743.341.588.85
Net Income
-3.9810.08-18.491.040.015.49
Earnings Per Share
-0.020.04-0.070.000.000.02
EPS Growth
---7075.86%-99.74%-

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.721.940.610.420.154.87
Total Debt
20.3724.4632.3927.1920.6424.28
Net Cash (Debt)
-17.65-22.51-31.78-26.76-20.49-19.42
Net Cash Growth
------
Net Cash Per Share
-0.07-0.09-0.13-0.11-0.08-0.08

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
17.4510.78-0.293.414.7219.61
Capital Expenditures
-8.42-0.02-1.79-1.32-22-16.18
Free Cash Flow
9.0310.76-2.082.09-17.293.44
Free Cash Flow Growth
270.95%-----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
30.51%40.14%12.47%73.63%40.17%41.28%
Operating Margin
-8.12%22.49%-38.38%25.13%8.70%19.48%
Pretax Margin
-3.68%21.05%-83.64%16.35%5.28%19.40%
Profit Margin
-9.78%18.37%-81.15%7.82%0.08%12.09%
FCF Margin
22.18%19.60%-9.14%15.72%-94.97%7.57%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-92.22-191.7319146.9148.70
P/FCF Ratio
156.1186.46-95.38-77.80
PS Ratio
34.6216.9514.4914.9915.445.89